Success Stories: Our Vigilance in This NIW Case Obtained an Analyst Commodity II from China Approval in the Field of Pharmacoepidemiology Without any RFE


Client’s Testimonial:

“I highly recommend North American Immigration Law Group to anyone who wants to file immigration related cases to USCIS. The attorneys here are very professional, knowledgeable, and experienced. There is no doubt that I will choose working with them again in future for any immigration relevant issues.”

On May 19th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for an Analyst Commodity II in the Field of Pharmacoepidemiology (Approval Notice).

General Field: Pharmacoepidemiology

Position at the Time of Case Filing: Analyst Commodity II

Country of Origin: China

State of Residence at the Time of Filing: Illinois

Approval Notice Date: May 19th, 2021

Processing Time: 7 months, 19 days

Case Summary:

Our client’s petition consisted of four recommendation letters secured by her fellow experts in the field of pharmacoepidemiology to demonstrate that her expertise in the field and her research on utilizing real-world evidence to improve drug safety, accelerate drug development, and reduce healthcare spending has both substantial merit and national importance. One of the recommenders opinionated:

“Over the last decade in the United States, there has been an increasing trend of gabapentinoid use among its citizens. As it has become a more common treatment for spinal cord injuries, diabetic neuropathy, and other chronic pain conditions, there has failed to be a commensurate increase in scientific understanding of the secondary health effects of this drug. [Client] has identified a significant risk of overdose when gabapentinoids are combined with opioids. She has also identified key statistical trends that highlight the need for healthcare providers to closely supervise prescriptions and off-label gabapentinoid intake in patients. Her research is educating healthcare providers on a growing public health threat, providing guidance for improved patient treatment, and supporting positive healthcare outcomes. Her research is, therefore, essential to national public health.”

The other recommenders also highlight her research, which is based on real-world data, is providing strong evidence of the effects of these drugs, improving patient treatment, and substantially enriching the field’s understanding of drug safety. Her scientific efforts, therefore, possess scientific merit of importance.

After thoroughly reviewing our client’s credentials, we were sure that our client must be allowed to continue her work here in the United States without any hurdles. Also, we added the following details in her petition packet to bolster her EB-2 NIW (National Interest Waiver) case.

  • Our client, an analyst commodity II armed with a Ph.D. in pharmaceutical science, and a profound understanding of the field unquestionably proves her to be a fit for the national interest waiver visa. We discussed her research on utilizing real-world evidence to evaluate the effectiveness and safety of medications, analyze health care utilization and costs, and investigate treatment patterns in order to improve drug safety, accelerate drug development, and reduce healthcare spending, which is relevant to the public health and health care efficiency.
  • We also noted that she has an exceptional record of publication; the 10 peer-reviewed journal articles (6 of them first-authored) she published in no fewer than 2 highly ranked peer-reviewed journals, which has been cited 101 times so far, which confirms that fellow experts from around the world rely on our client’s findings in order to support their own studies. This notable publication and citation record strengthens the fact that her research output benefits the national interest in public health and for this reason, her research must continue to be supported in the United States.
  • Moreover, we observed that she has performed review work for several highly acclaimed journals, which speaks to the level of recognition she has attained across the field. Having conducted at least 6 reviews indeed indicates that she is an expert in the field.

By the end, we incorporated the employment letter confirming her current position, and a letter confirming the intent of her employer to hire her in a full-time position along with information regarding her current employer. Therefore, with a triumph rate of 17K+ approved I-140 petitions, the North America Immigration Law Group is comprehended for having remarkable expertise in articulating employment-based visas, thus, this case is counted as one more successful accomplishment for our law firm. We truly thank our client for choosing us for presenting her I-140 NIW case. We wish her well as she pursues her chosen field here in the United States.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.